One year after ICU admission for severe community-acquired pneumonia of bacterial, viral or unidentified etiology. What are the outcomes?
Activities of Daily Living
Aged
Aged, 80 and over
Community-Acquired Infections
/ microbiology
Dyspnea
/ etiology
Female
Functional Status
Hospitalization
Humans
Intensive Care Units
Kaplan-Meier Estimate
Male
Middle Aged
Pneumonia, Bacterial
/ diagnosis
Pneumonia, Viral
/ mortality
Proportional Hazards Models
Respiration, Artificial
Retrospective Studies
Severity of Illness Index
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
01
04
2020
accepted:
29
11
2020
entrez:
14
12
2020
pubmed:
15
12
2020
medline:
3
2
2021
Statut:
epublish
Résumé
Multiplex polymerase chain reaction (mPCR) for respiratory virus testing is increasingly used in community-acquired pneumonia (CAP), however data on one-year outcome in intensive care unit (ICU) patients with reference to the causative pathogen are scarce. We performed a single-center retrospective study in 123 ICU patients who had undergone respiratory virus testing for CAP by mPCR and with known one-year survival status. Functional status including dyspnea (mMRC score), autonomy (ADL Katz score) and need for new home-care ventilatory support was assessed at a one-year post-ICU follow-up. Mortality rates and functional status were compared in patients with CAP of a bacterial, viral or unidentified etiology one year after ICU admission. The bacterial, viral and unidentified groups included 19 (15.4%), 37 (30.1%), and 67 (54.5%) patients, respectively. In multivariate analysis, one-year mortality in the bacterial group was higher compared to the viral group (HR 2.92, 95% CI 1.71-7.28, p = 0.02) and tended to be higher compared to the unidentified etiology group (p = 0.06); but no difference was found between the viral and the unidentified etiology group (p = 0.43). In 64/83 one-year survivors with a post-ICU follow-up consultation, there were no differences in mMRC score, ADL Katz score and new home-care ventilatory support between the groups (p = 0.52, p = 0.37, p = 0.24, respectively). Severe dyspnea (mMRC score = 4 or death), severe autonomy deficiencies (ADL Katz score ≤ 2 or death), and major adverse respiratory events (new home-care ventilatory support or death) were observed in 52/104 (50.0%), 47/104 (45.2%), and 65/104 (62.5%) patients, respectively; with no difference between the bacterial, viral and unidentified group: p = 0.58, p = 0.06, p = 0.61, respectively. CAP of bacterial origin had a poorer outcome than CAP of viral or unidentified origin. At one-year, impairment of functional status was frequently observed, with no difference according to the etiology.
Identifiants
pubmed: 33315946
doi: 10.1371/journal.pone.0243762
pii: PONE-D-20-09347
pmc: PMC7735561
doi:
Banques de données
Dryad
['10.5061/dryad.vx0k6djpc']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0243762Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Respir Med. 2010 Jun;104(6):773-9
pubmed: 20417082
Stat Med. 2008 Jan 15;27(1):36-46
pubmed: 17634969
J Cardiothorac Vasc Anesth. 2019 Jan;33(1):72-79
pubmed: 30049521
J Infect. 2014 Jun;68(6):534-41
pubmed: 24534605
Crit Care. 2015 Oct 02;19:356
pubmed: 26428615
Respiration. 2016;92(5):286-294
pubmed: 27649510
Acta Anaesthesiol Scand. 2011 Nov;55(10):1254-60
pubmed: 22092131
Intensive Care Med. 2019 Feb;45(2):159-171
pubmed: 30706119
Am J Respir Crit Care Med. 2002 Sep 1;166(5):717-23
pubmed: 12204871
Curr Opin Crit Care. 2018 Feb;24(1):35-40
pubmed: 29189296
JAMA. 2010 Oct 27;304(16):1787-94
pubmed: 20978258
Ann Intensive Care. 2018 Aug 15;8(1):84
pubmed: 30112650
PLoS One. 2016 Feb 05;11(2):e0148741
pubmed: 26849359
JAMA. 1999 Jan 27;281(4):354-60
pubmed: 9929089
J Crit Care. 2015 Aug;30(4):721-6
pubmed: 25818842
JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
Crit Care. 2014 Apr 01;18(2):R58
pubmed: 24690444
Intensive Care Med. 2006 Jul;32(7):1022-9
pubmed: 16791664
Chest. 2012 Sep;142(3):583-592
pubmed: 22948576
Crit Care Med. 2003 May;31(5):1373-81
pubmed: 12771605
Br Med J. 1959 Aug 29;2(5147):257-66
pubmed: 13823475
J Clin Virol. 2017 Jul;92:48-51
pubmed: 28527970
Crit Care. 2011;15(5):R209
pubmed: 21914220
PLoS One. 2016 Jan 04;11(1):e0145929
pubmed: 26727202
Am J Respir Crit Care Med. 2012 Aug 15;186(4):325-32
pubmed: 22700859
Stat Med. 2003 Apr 15;22(7):1069-82
pubmed: 12652554
Stat Med. 2007 Aug 15;26(18):3385-97
pubmed: 17149799
Eur J Clin Microbiol Infect Dis. 2013 May;32(5):705-10
pubmed: 23274861
Chest. 2005 Dec;128(6):3810-6
pubmed: 16354849
Curr Opin Crit Care. 2018 Dec;24(6):531-539
pubmed: 30239410
Infect Dis Clin North Am. 2009 Sep;23(3):503-20
pubmed: 19665080
Lancet. 2015 Sep 12;386(9998):1097-108
pubmed: 26277247
Clin Infect Dis. 2014 Jul 1;59(1):62-70
pubmed: 24729498
N Engl J Med. 2003 Feb 20;348(8):683-93
pubmed: 12594312
PLoS One. 2018 Jan 25;13(1):e0191721
pubmed: 29370285
Chest. 2010 Mar;137(3):552-7
pubmed: 19880910
Crit Care. 2016 Oct 25;20(1):375
pubmed: 27852281
J Intensive Care. 2016 Aug 11;4:56
pubmed: 27525106
Pediatr Infect Dis J. 2008 Dec;27(12):1103-7
pubmed: 18978518